Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.

Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores

Indexado en
  • Índice Copérnico
  • Google Académico
  • sherpa romeo
  • Abrir puerta J
  • Revista GenámicaBuscar
  • Infraestructura Nacional del Conocimiento de China (CNKI)
  • Biblioteca de revistas electrónicas
  • Búsqueda de referencia
  • Universidad Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catálogo en línea SWB
  • Biblioteca Virtual de Biología (vifabio)
  • publones
  • Fundación de Ginebra para la educación y la investigación médicas
  • Pub Europeo
  • ICMJE
Comparte esta página

Abstracto

SMIPN - Surgical Management of Infected pancreatic necrosis, a case series in a 4th level Hospital in Bogota ? Colombia University

Carlos Eduardo Rey Chaves

The first aim of our study, it is to describe our experience in the surgical management of the infected pancreatic necrosis, in the period of time between 2014 to 2019. We search in the database of the general surgery service, all the patients with pancreatitis and infected pancreatic necrosis that undergo surgical drenaige; we use a quantitative approach, retrospective, in between 2014-2019. We have 320 patients with pancreatitis, and 30 patients with infected pancreatic necrosis (9.3% of incidence vs 10-15% compared with world literature), our mean age was 57 years, 70% of our patients were men. The open approach was 83%, with a high mortality rate with 43%. We observe, in terms of postoperative organ failure, an improvement with the laparoscopic approach (20% vs 4% with open approach). We conclude that infected pancreatic necrosis, it is still a surgical challenge, however, the laparoscopic approach shows incredible results in terms of mortality, total hospital stays, ICU stay, and mortality vs open approach. In our study, we observe, a possible use of procalcitonin as a biomarker to predict mortality in those patients, but more prospective studies are necessary.